Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 2, 2004, Pages 305-310

  Flatz, L ^a   Cottagnoud, M ^a   Kuhn F ^a   Entenza, J ^b   Stucki, A ^c   Cottagnoud, P ^c  

^a Spital Bern Ziegler ^*  (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

lactam antibiotics; Quinolones; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE IV; GARENOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; PROTEIN PARC; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME SUBUNIT; GENE MUTATION; GENETIC CODE; IN VITRO STUDY; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PENICILLIN RESISTANCE; RABBIT; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEPHALOSPORINS; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PENICILLIN RESISTANCE; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE;

EID: 1242352628     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh082     Document Type: Article

References (23)

1. Jacobs, M. R. (1999). Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. American Journal of Medicine 106, 19S-25S; discussion 48S-52S.
2. Muhlemann, K., Matter, H. C., Tauber, M. G. et al. (2003). Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999. Journal of Infectious Diseases 187, 589-96.
3. Chen, D. K., McGeer, A., de Azavedo, J. C. et al. (1999). Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. New England Journal of Medicine 341, 233-9.
4. Davidson, R., Cavalcanti, R., Brunton, J. L. et al. (2002). Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. New England Journal of Medicine 346, 747-50.
5. Kaplan, S. L. & Mason, E. O., Jr (1998). Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clinical Microbiology Reviews 11, 628-44.
6. McCullers, J. A., English, B. K. & Novak, R. (2000). Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. Journal of Infectious Diseases 181, 369-73.
7. Dacey, R. G. & Sande, M. A. (1974). Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrobial Agents and Chemotherapy 6, 437-41.
8. Nau, R., Kaye, K., Sachdeva, M. et al. (1994). Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrobial Agents and Chemotherapy 38, 1186-9.
9. Simon, H. J. & Yin, E. J. (1970). Microbioassay of antimicrobial agents. Applied Microbiology 19, 573-9.
10. Tauber, M. G., Hackbarth, C. J., Scott, K. G. et al. (1985). New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrobial Agents and Chemotherapy 27, 340-2.
11. Cottagnoud, P. & Tomasz, A. (1993). Triggering of pneumococcal autolysis by lysozyme. Journal of Infectious Diseases 167, 684-90.
12. Cottagnoud, P., Acosta, F., Cottagnoud, M. et al. (2000). Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrobial Agents and Chemotherapy 44, 2179-81.
13. Eliopoulos, G. M. & Moellering, R. C. (1996). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 330-96. Williams & Wilkins, Baltimore, MD, USA.
14. Entenza, J. M., Vouillamoz, J., Glauser, M. P. et al. (1997). Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus, aureus. Antimicrobial Agents and Chemotherapy 41, 1662-7.
15. Sambrook, J., Fritsch, E. F. & Manaiatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
16. Pan, X. S. & Fisher, L. M. (1996). Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. Journal of Bacteriology 178, 4060-9.
17. Cottagnoud, P., Entenza, J. M., Cottagnoud, M. etal. (2001). Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiology 1, 9.
18. Friedland, I. R. & McCracken, G. H., Jr (1994). Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 377-82.
19. Scotton, P. G., Pea, F., Giobbia, M. et al. (2001). Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis. Clinical Infectious Diseases 33, e109-11.
20. Gerber, C. M., Cottagnoud, M., Neftel, K. A. et al. (1999). Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. European Journal of Clinical Microbiology and Infectious Diseases 18, 866-70.
21. Gerber, C. M., Cottagnoud, M., Neftel, K. et al. (2000). Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Journal of Antimicrobial Chemotherapy 45, 63-8.
22. Nau, R., Schmidt, T., Kaye, K. et al. (1995). Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrobial Agents and Chemotherapy 39, 593-7.
23. Davies, T. A., Pankuch, G. A., Dewasse, B. E. et al. (1999). In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 43, 1177-82.